Navigation Links
BioXcel Forms a Corporate Advisory Board for Its Next Phase of Growth
Date:10/8/2008

NEW HAVEN, Conn., Oct. 8 /PRNewswire/ -- BioXcel Corporation today announced the appointment of three distinguished biopharma executives to its Corporate Advisory Board (CAB). R. Christopher Seaton, SVP of Global Transactions, Bayer Healthcare, Martha Matteo, Ph.D., Past President of SCIP and recently retired from Boehringer Ingelheim Pharmaceuticals, Inc., where she was the Director for Knowledge Management, and Kevin Rakin, Chairman and CEO of Advanced BioHealing, Inc., are known throughout the biopharma world as outstanding and highly experienced pharmaceutical professionals.

BioXcel, a global, business/IP analytics company, will work closely with these industry leaders to design and develop new strategies for its next phase of corporate growth -- targeted to the pharmaceutical, biotechnology, medical device, diagnostic, investment, legal, and related support industries.

"We are delighted to be associated with such a high caliber of experienced pharmaceutical executives," said Vimal D. Mehta, Chairman and co-founder of BioXcel. "Their presence on BioXcel's CAB will assure our planned corporate growth and development at every point in our business model -- from assisting clients with R&D services to all the commercial challenges facing today's complex global industries. BioXcel's senior management, executives, and staff join me in welcoming Christopher, Martha, and Kevin to our valued advisor group. With their advice and guidance, BioXcel is now positioned to achieve our next level of planned business growth, maturity, and service capabilities."

About BioXcel Corporation (http://www.bioxcel.com)

Headquartered in New Haven, CT, BioXcel offers business analytics and intellectual property services to the healthcare sector, life science companies, and related industries worldwide. BioXcel's unique, hybrid delivery model capitalizes on US-based expertise and the BioXcel Analytical and Commercial Center (BACC) in India. This "on-shore/off-shore model" leverages highly flexible analytics teams (MS, MTech, PhDs, MDs, Patent Agents, and MBAs) to provide quality services with outstanding breadth and depth.

For additional information, contact:

Krishnan Nandabalan, Ph.D.

1.203.458.1435

knandabalan@bioxcel.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE BioXcel Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BioXcel Expands Its Capability in Business Analytics Support Services
2. NASA technology forms the basis for a new nanotechnology company
3. CellCyte Genetics Corp. Forms Device Division to Develop and Manufacture Stem Cell Cultivation and Replication Products
4. iGuard Transforms Drug Safety Alert and Update Process
5. ADM Forms Industrial Chemicals Group
6. Transgenomic, Inc. Forms Scientific Advisory Board
7. Anthera Pharmaceuticals Forms Scientific Advisory Board
8. Technology Transforms Market Research in Pharmaceutical Industry
9. Microchip Biotechnologies, Inc. Collaborating With Stanford University on Developing a Front End Microfluidic-Based Sample Preparation System for Pyrosequencing Platforms
10. febit Forms Scientific Advisory Board
11. Champions Biotechnology, Inc. Appoints New Board Members and Forms Management Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... the three Winners and six Finalists of the 2017 Blavatnik Regional Awards for ... Blavatnik Family Foundation and administered by the New York Academy of Sciences to ...
(Date:10/12/2017)... CA (PRWEB) , ... October ... ... (https://www.onramp.bio/ ) has launched Rosalind™, the first-ever genomics analysis platform specifically designed ... bioinformatics complexity. Named in honor of pioneering researcher Rosalind Franklin, who made ...
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia Inc ... hosting a Webinar titled, “Pathology is going digital. Is your lab ready?” with ... adoption best practices and how Proscia improves lab economics and realizes an increase ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today ... designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) ... able to cross the cell membrane and bind intracellular STAT3 and inhibit its ...
Breaking Biology Technology:
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by Solution ... Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to 2022", ... 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at a ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... , April 11, 2017 NXT-ID, ... security technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate ... ... NXT-ID, we look forward to their guidance and benefiting from ...
(Date:4/5/2017)... 4, 2017 KEY FINDINGS The ... at a CAGR of 25.76% during the forecast period ... primary factor for the growth of the stem cell ... MARKET INSIGHTS The global stem cell market ... and geography. The stem cell market of the product ...
Breaking Biology News(10 mins):